LYB vs RARE · P/E 21, rev $16.37B vs rev $350.0M
LyondellBasell Industries NV (LYB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. RARE currently screens at market cap $2.79B.
Not investment advice. Open the LYB and RARE stock pages for the full models.
Not investment advice.